Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Mar 28;11(4):e01317.
doi: 10.14309/crj.0000000000001317. eCollection 2024 Apr.

Severe Elevated Bile Acids in Early Pregnancy

Affiliations
Case Reports

Severe Elevated Bile Acids in Early Pregnancy

Lucas Fass et al. ACG Case Rep J. .

Abstract

Intrahepatic cholestasis of pregnancy (ICP) typically presents in the second half of pregnancy. Severe ICP is associated with increased risk of stillbirth. Little is known regarding elevated bile acids in the first trimester. We present a case of severely elevated bile acids in the first trimester, resistant to conservative management, in a patient with pre-existing cholestatic liver disease and aortic valve disease requiring anticoagulation. Therapeutic plasma exchange was used. In those with pre-existing cholestatic disease, early bile acid elevation is likely distinct from ICP, and conservative strategies may not be useful. In addition, therapeutic enoxaparin appears safe in therapeutic plasma exchange.

Keywords: Bile acids; Pregnancy; ductopenia; ntrahepatic cholestasis of pregnancy; vanishing bile duct syndrome.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Histology of patients severe ductopenia. (A) A normal portal triad (40×). (B) Several portal triads with ductopenia (20×). (C) Magnified triad with no bile duct visualized (40×). BD, bile duct; HA, hepatic artery; HV, hepatic vein.
Figure 2.
Figure 2.
Bile acid trend throughout gestation. TPE, therapeutic plasma exchange.

Similar articles

Cited by

  • Intrahepatic cholestasis of pregnancy.
    Dajti E, Tripodi V, Hu Y, Estiù MC, Shan D, Mazzella G, Azzaroli F. Dajti E, et al. Nat Rev Dis Primers. 2025 Jul 24;11(1):51. doi: 10.1038/s41572-025-00633-2. Nat Rev Dis Primers. 2025. PMID: 40707479 Review.

References

    1. Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: Results of aggregate and individual patient data meta-analyses. Lancet. 2019;393(10174):899–909. Erratum in: Lancet. 2019;393(10176):1100. - PMC - PubMed
    1. Vasavan T, Williamson C, Chapter 65–sex and cardiac electrophysiology: Fetal arrhythmia in intrahepatic cholestasis of pregnancy In: Malik M. (eds). Sex and Cardiac Electrophysiology, Academic Press, Elsevier USA, Philidelphia PA, USA: 2020, 727–35, ISBN 9780128177280.
    1. Kaplan AA. Therapeutic plasma exchange: Core curriculum 2008. Am J Kidney Dis. 2008;52(6):1180–96. - PubMed
    1. Alallam A, Barth D, Heathcote EJ. Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: Case reports. Can J Gastroenterol. 2008;22(5):505–7. - PMC - PubMed
    1. Mathias A, Wax JR, Pinette MG, Cartin A, Blackstone J. Progressive familial intrahepatic cholestasis complicating pregnancy. J Matern Fetal Neonatal Med. 2009;22(9):816–8. - PubMed

Publication types